Geron
GERN
#6178
Rank
S$1.14 B
Marketcap
S$1.79
Share price
3.36%
Change (1 day)
-65.23%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -S$60.87 Million

According to Geron's latest financial reports the company's current earnings are S$0.18 Billion. In 2024 the company made an earning of -S$0.21 Billion, an increase over its 2023 earnings that were of -S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$60.87 Million-69.78%
2024 -S$0.21 Billion-11.23%
2023 -S$0.23 Billion30.22%
2022 -S$0.18 Billion20.15%
2021 -S$0.15 Billion50.08%
2020 -S$96.63 Million4.46%
2019 -S$92.5 Million130.68%
2018 -S$40.1 Million8.84%
2017 -S$36.84 Million-3.08%
2016 -S$38.01 Million-22080.6%
2015 S$0.17 M-100.38%
2014 -S$45.93 Million-7.14%
2013 -S$49.46 Million
2011 -S$0.12 Billion19.04%
2010 -S$98.29 Million8.45%
2009 -S$90.64 Million-2.51%
2008 -S$92.97 Million14.65%
2007 -S$81.09 Million32.68%
2006 -S$61.12 Million25.59%
2005 -S$48.67 Million4.36%
2004 -S$46.63 Million19.73%
2003 -S$38.95 Million-15.46%
2002 -S$46.07 Million1.94%
2001 -S$45.19 Million33.59%
2000 -S$33.83 Million27.53%
1999 -S$26.53 Million63.13%
1998 -S$16.26 Million15.6%
1997 -S$14.07 Million-10.66%
1996 -S$15.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-S$12.25 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.75 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.14 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.04 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-S$89.35 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA